CD274 and cancer: For example, the TREM1 pathway could be beneficially associated with M1 tumoricidal macrophages, and the predicted inhibition of the PD1/PD-L1 cancer immunotherapy pathway in IL27-containing groups could act to enhance T cell activation, proliferation, and survival [34].